Mersana Therapeutics buy Truist Financial Co.
Start price
29.02.24
/
50%
€5.00
Target price
28.02.25
€8.30
Performance (%)
-90.28%
End price
01.03.25
€0.49
Summary
This prediction ended on 01.03.25 with a price of €0.49. The BUY prediction by Truist_Financial_Co_ for Mersana Therapeutics performed very badly with a performance of -90.28%. Truist_Financial_Co_ has a follow-up prediction for Mersana Therapeutics where he still thinks Mersana Therapeutics is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | - | - | - |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Mersana Therapeutics
Stopped prediction by Truist_Financial_Co_ for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.30
16.05.25
16.05.25
€8.93
16.05.26
16.05.26
-13.68%
17.05.26
17.05.26
